NASDAQ
No price data available for this timeframe.
Merck secures a positive CHMP opinion to expand Winrevair's PAH use, potentially broadening treatment to adult patients across WHO FC II-IV....
Corient Private Wealth LLC increased its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 85.6% in the undefined quarter, according to the company in its most recent filing with the Securities an...
Caxton Associates LLP grew its holdings in Merck and Co., Inc. (NYSE: MRK) by 23.3% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi...
Cullen Capital Management LLC grew its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 1.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commis...
Representative Julie Johnson (D-Texas) recently sold shares of Merck and Co., Inc. (NYSE: MRK). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 a...
Caldwell Trust Co acquired a new stake in Merck and Co., Inc. (NYSE: MRK) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acqui...
Shares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly. Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their ...
The rapid rise of artificial intelligence (AI) has transformed the stock market in recent years, powering massive gains in technology giants and growth-oriented investments. At the same time, dividend...
AQR Capital Management LLC lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 13.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional...
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff....